Drug & Device Safety Atlas

FDA recall record · openFDA

Abbott Diabetes Care, Inc.

10 FDA recalls on record (2023–2025) — 10 device. 10 still ongoing.

8
Class I (most serious)
2
Class II
0
Class III
10
ongoing

How to read this. A recall count is not a quality verdict — large manufacturers recall more simply by volume, and a voluntary recall is the safety system working as intended. The signal to weight is the Class I count (the FDA's most-serious tier — reasonable probability of serious harm or death) and whether recalls are still ongoing. Most recalls are Class II/III. "Ongoing" reflects openFDA's last-published status — device recalls often stay marked ongoing long after they're resolved in practice; confirm current status at the FDA.

Most common reasons

Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low gluco 4
Lithium-ion batteries in glucose monitoring system readers may swell, overheat, or pose fire hazard. Only use the chargi 3
Users of the FreeStyle Libre 3 sensors reported situations where they were receiving erroneously high glucose results. T 1
If blood glucose monitoring system users attempt to start a new sensor, when the old sensor wasn't used for the full 14- 1
If using affected glucose monitoring app on Android 13 Operating System, extended periods of signal loss may be experien 1

Recalls

RECORDED — these are the FDA's published recall enforcement records (openFDA). Recalls are listed under the exact firm name as filed; a large manufacturer may also file under name variants, so this may not be the company's complete cross-variant record — confirm at the FDA recall database. This page informs and routes; it is not medical advice or a verdict on the company.

Machine-readable: JSON-LD · Markdown